Structure-Function Relation of Phospholamban: Modulation of Channel Activity as a Potential Regulator of SERCA Activity

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Smeazzetto, Serena ^a   Saponaro, Andrea ^b   Young, Howard S ^c   Moncelli, Maria Rosa ^a   Thiel, Gerhard ^d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF ALBERTA   (Canada)

^d DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; MONOMER; PHOSPHOLAMBAN; POTASSIUM ION; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHANNEL GATING; CONTROLLED STUDY; ENZYME INHIBITION; MEMBRANE CONDUCTANCE; MOLECULAR SIZE; POROSITY; POTASSIUM TRANSPORT; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SARCOPLASMIC RETICULUM; STRUCTURE ACTIVITY RELATION;

CALCIUM; CALCIUM-BINDING PROTEINS; ENZYME ACTIVATION; HUMANS; LIPID BILAYERS; PHOSPHORYLATION; POINT MUTATION; POTASSIUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84871879382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052744     Document Type: Article

References (36)

1. Schmidt AG, Edes I, Kranias EG, (2001) Phospholamban: a promising therapeutic target in heart failure? Cardiovasc Drugs Ther 15: 387-396.
2. Tadini-Buoninsegni F, Bartolommei G, Moncelli MR, Guidelli R, Inesi G, (2006) Pre-steady State Electrogenic Events of Ca2+/H+ Exchange and Transport by the Ca2+-ATPase. J Biol Chem 281: 37720-37727.
3. Zamoon J, Mascioni A, Thomas DD, Veglia G, (2003) NMR Solution Structure and Topological Orientation of Monomeric Phospholamban in Dodecylphosphocholine Micelles. Biophys J 85: 2589-2598.
4. Traaseth NJ, Verardi R, Torgersen KD, Karim CB, Thomas DD, et al. (2007) Spectroscopic validation of the pentameric structure of phospholamban. Proc Natl Acad Sci USA 104: 14676-14681.
5. Cornea RL, Jones LR, Autry JM, Thomas DD, (1997) Mutation and Phosphorylation Change the Oligomeric Structure of Phospholamban in Lipid Bilayers. Biochemistry 36: 2960-2967.
6. Kimura Y, Kurzydlowski K, Tada M, MacLennan DH, (1997) Phospholamban Inhibitory Function Is Activated by Depolymerization. J Biol Chem 272: 15061-15064.
7. Reddy LG, Jones LR, Thomas DD, (1999) Depolymerization of Phospholamban in the Presence of Calcium Pump: A Fluorescence Energy Transfer Study. Biochemistry 38: 3954-3962.
8. Stokes DL, Pomfret AJ, Rice WJ, Glaves JP, Young HS, (2006) Interactions between Ca2+-ATPase and the Pentameric Form of Phospholamban in Two-Dimensional Co-Crystals. Biophys J 90: 4213-4223.
9. Oxenoid K, Chou J, (2005) The structure of phospholamban pentamer reveals a channel-like architecture in membranes. Proc Natl Acad Sci USA 102: 10870-10875.
10. Tatulian S, Jones L, Reddy L, Stokes D, Tamm L, (1995) Secondary structure and orientation of phospholamban reconstituted in supported bilayers from polarized attenuated total reflection FTIR spectroscopy. Biochemistry 34: 4448-4456.
11. Arkin IT, Rothman M, Ludlam CFC, Aimoto S, Engelman DM, et al. (1995) Structural Model of the Phospholamban Ion Channel Complex in Phospholipid Membranes. J Mol Biol 248: 824-834.
12. Smeazzetto S, Schroder I, Thiel G, Moncelli MR, (2011) Phospholamban generates cation selective ion channels. Phys Chem Chem Phys 13: 12935-12939.
13. Kovacs R, Nelson M, Simmerman H, Jones L, (1988) Phospholamban forms Ca2+-selective channels in lipid bilayers. J Biol Chem 263: 18364-18368.
14. Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, et al. (2003) Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299: 1410-1413.
15. Ha KN, Masterson LR, Hou Z, Verardi R, Walsh N, et al. (2011) Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A. Proc Natl Acad Sci U S A 108: 2735-2740.
16. Glaves JP, Trieber CA, Ceholski DK, Stokes DL, Young HS, (2011) Phosphorylation and Mutation of Phospholamban Alter Physical Interactions With the Sarcoplasmic Reticulum Calcium Pump. J Mol Biol 405: 707-723.
17. Trieber CA, Afara M, Young HS, (2009) Effects of Phospholamban Transmembrane Mutants on the Calcium Affinity, Maximal Activity, and Cooperativity of the Sarcoplasmic Reticulum Calcium Pump. Biochemistry 48: 9287-9296.
18. Cornea RL, Autry JM, Chen Z, Jones LR, (2000) Reexamination of the Role of the Leucine/Isoleucine Zipper Residues of Phospholamban in Inhibition of the Ca2+ Pump of Cardiac Sarcoplasmic Reticulum. J Biol Chem 275: 41487-41494.
19. Ceholski DK, Trieber CA, Young HS, (2012) Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy. J Biol Chem 287: 16521-16529.
20. Robia SL, Campbell KS, Kelly EM, Hou Z, Winters DL, et al. (2007) Förster Transfer Recovery Reveals That Phospholamban Exchanges Slowly From Pentamers but Rapidly From the SERCA Regulatory Complex. Circ Res 101: 1123-1129.
21. Cabrita LD, Gilis D, Robertson AL, Dehouck Y, Rooman M, et al. (2007) Enhancing the stability and solubility of TEV protease using in silico design. Protein Sci 16: 2360-2367.
22. Douglas JL, Trieber CA, Afara M, Young HS, (2005) Rapid, high-yield expression and purification of Ca2+-ATPase regulatory proteins for high-resolution structural studies. Protein Expr Purif 40: 118-125.
23. Montal M, (1987) Reconstitution of channel proteins from excitable cells in planar lipid bilayer membranes. J Membr Biol 98: 101-115.
24. Hille B (1992) Ionic Channels of Excitable Membranes.: Sunderland, MA: Sinauer Assocs.
25. Smart OS, Breed J, Smith GR, Sansom MS, (1997) A novel method for structure-based prediction of ion channel conductance properties. Biophys J 72: 1109-1126.
26. Hinnah SC, Wagner R, Sveshnikova N, Harrer R, Soll Jr, (2002) The Chloroplast Protein Import Channel Toc75: Pore Properties and Interaction with Transit Peptides. Biophys J 83: 899-911.
27. Krasilnikov OV, Sabirov RZ, Ternovsky VI, Merzliak PG, Muratkhodjaev JN, (1992) A simple method for the determination of the pore radius of ion channels in planar lipid bilayer membranes. FEMS Microbiol Immunol 5: 93-100.
28. Arkin I, Adams P, Brünger A, Smith S, Engelman D, (1997) Structural perspectives of phospholamban, a helical transmembrane pentamer. Annu Rev Biophys Biomol Struct 26: 157-179.
29. Sansom M, Smith G, Smart O, Smith S, (1997) Channels formed by the transmembrane helix of phospholamban: a simulation study. Biophys Chem 69: 269-281.
30. Verardi R, Shi L, Traaseth NJ, Walsh N, Veglia G, (2011) Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method. Proc Natl Acad Sci U S A 108: 9101-9106.
31. Brittsan AG, Kranias EG, (2000) Phospholamban and Cardiac Contractile Function. J Mol Cell Cardiol 32: 2131-2139.
32. MacLennan DH, Kranias EG, (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4: 566-577.
33. Favero TG, Zable AC, Abramson JJ, (1995) Hydrogen peroxide stimulates the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum. J Biol Chem 270: 25557-25563.
34. Fink RH, Stephenson DG, (1987) Ca2+-movements in muscle modulated by the state of K+-channels in the sarcoplasmic reticulum membranes. Pflugers Arch 409: 374-380.
35. Allard B, Moutin M-J, Ronjat M, (1992) BisG10, a K+ channel blocker, affects the calcium release channel from skeletal muscle sarcoplasmic reticulum. FEBS Letters 314: 81-84.
36. Maffeo C, Aksimentiev A, (2009) Structure, Dynamics, and Ion Conductance of the Phospholamban Pentamer. Biophys J 96: 4853-4865.